Physician profile
Torin J Cunningham
NPI 1861436891
$96,226.04
in general payments reported to CMS, 2019-2025
16 companies · $14K in 2025
The $14K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $6,241 · 2021: $4,656 · 2022: $13K · 2023: $11K · 2024: $29K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $31K · Travel and Lodging: $13K · Royalty Or License: $6,617 · Food and Beverage: $2,748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $30,700.00 |
| Travel and Lodging | $13,322.88 |
| Royalty Or License | $6,617.00 |
| Food and Beverage | $2,748.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart USA INC | $50,891.65 | 2022-2025 | Perla Tl, Perla C, Romeo 2 |
| Spineart Sa | $30,523.77 | 2019-2024 | Romeo 2 - 25d Deformity Screw, Baguera-C |
| Alphatec Spine, INC | $7,227.80 | 2019 | |
| Seaspine Orthopedics Corporation | $5,606.45 | 2019-2020 | |
| Nuvasive, INC. | $868.91 | 2019-2022 | |
| Medical Device Business Services, INC. | $515.64 | 2023 | Expedium |
| Zimmer Biomet Holdings, INC. | $263.79 | 2019-2023 | Stratum Foot Plating System |
| Biomarin Pharmaceutical INC. | $94.88 | 2020-2022 | |
| Baxter Healthcare | $51.68 | 2025 | Floseal |
| Saxum Surgical, INC. | $43.87 | 2023 | |
| Zimvie INC. | $33.94 | 2023 | |
| Orthopediatrics Corp. | $27.87 | 2019 | |
| Medtronic, INC. | $23.94 | 2022 | |
| Stryker Corporation | $18.88 | 2022 | |
| Depuy Synthes Sales INC. | $18.34 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicrea USA, Corp. | $14.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Torin Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.